ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Research Projects Banner

Research Projects

Therapeutic outcomes with second-line drug exposures in a cohort of South African and Indian patients with drug resistant TB: A pharmacokineticpharmacodynamic assessment

Implementing Organization

Principal Investigator
Dr. Tester F Ashavaid
Director
|
P.D. Hinduja National Hospital & Medical Research Centre, Mumbai

Related Research

View All
Funding Organization
Funding Organization
Department of Biotechnology (DBT)
Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
Drug resistant TB
Start Year
2018
End Year
2021
Sanction Amount
₹ 1.80 Cr
Status
Completed
Contact
dr tashavaid @hindujahospital.com
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
No. of Patents
Filed : 00
Grant : 00
Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
arrowtop
Latest Updates
Loading…
Recently added across the portal